No deals were found in the last 365 days.
No deals were found in the last 365 days.
| Notifier | Holding | Value* |
|---|---|---|
| Carolyn Cross | 156,314,029 | £20,711,609 |
| Nicolas Loebel | 3,538,991 | £468,916 |
| Junaid Bajwa | 1,193,697 | £158,165 |
| Jean Duvall | 1,163,529 | £154,168 |
| Jean Charest | 353,356 | £46,820 |
| Notifier** | Holding | Value* |
|---|---|---|
| Carolyn Cross | 120,161,319 | £15,921,375 |
| M&G Plc | 74,268,775 | £9,840,613 |
| hInsight-NX, LLC | 42,272,654 | £5,601,127 |
| Robert Cross | 37,772,652 | £5,004,876 |
| Albemarle Life Sciences Fund | 15,105,882 | £2,001,529 |
| CRUX Asset Management | 9,298,090 | £1,231,997 |
| Chelverton Asset Management | 7,957,311 | £1,054,344 |
| Currency | UK Pounds |
| Share Price | 13.25p |
| Change Today | -0.75p |
| % Change | -5.36 % |
| 52 Week High | 18.00 |
| 52 Week Low | 8.00 |
| Volume | 1,018,247 |
| Shares Issued | 561.22m |
| Market Cap | £74.36m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:31 | 100,000 @ 13.50p |
| 17:07 | 25,000 @ 13.25p |
| 15:38 | 50,000 @ 13.22p |
| 16:28 | 45,340 @ 13.22p |
| 16:03 | 1,333 @ 13.50p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research